Table S1 from Immunotherapy of Ipilimumab and Nivolumab in Patients with Advanced Neuroendocrine Tumors: A Subgroup Analysis of the CA209-538 Clinical Trial for Rare Cancers
openalex（2023）
关键词
Neuroendocrine Tumors,Biomarkers for Immunotherapy,Pancreatic Neuroendocrine Tumors,Tumor Classification,Immunotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要